Holger Jahn

8.8k total citations · 1 hit paper
118 papers, 4.5k citations indexed

About

Holger Jahn is a scholar working on Physiology, Psychiatry and Mental health and Behavioral Neuroscience. According to data from OpenAlex, Holger Jahn has authored 118 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 26 papers in Psychiatry and Mental health and 21 papers in Behavioral Neuroscience. Recurrent topics in Holger Jahn's work include Stress Responses and Cortisol (21 papers), Alzheimer's disease research and treatments (17 papers) and Dementia and Cognitive Impairment Research (14 papers). Holger Jahn is often cited by papers focused on Stress Responses and Cortisol (21 papers), Alzheimer's disease research and treatments (17 papers) and Dementia and Cognitive Impairment Research (14 papers). Holger Jahn collaborates with scholars based in Germany, United States and Switzerland. Holger Jahn's co-authors include Klaus Wiedemann, Falk Kiefer, Michael Kellner, Alexander Yassouridis, Sönke Arlt, Christian Otte, Mildred Schick, Dieter Naber, Steffen Moritz and Rüdiger Holzbach and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and PLoS ONE.

In The Last Decade

Holger Jahn

107 papers receiving 4.4k citations

Hit Papers

Memory loss in Alzheimer's disease 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holger Jahn Germany 37 1.2k 1.1k 881 794 589 118 4.5k
Ingvar Karlsson Sweden 40 883 0.7× 1.4k 1.2× 719 0.8× 1.1k 1.3× 1.0k 1.8× 97 5.2k
Kelly Cosgrove United States 36 1.5k 1.2× 1.0k 0.9× 1.8k 2.0× 398 0.5× 687 1.2× 142 5.3k
Joana Almeida Palha Portugal 45 1.4k 1.1× 891 0.8× 792 0.9× 386 0.5× 843 1.4× 106 4.9k
Miho Ota Japan 38 1.2k 1.0× 1.0k 0.9× 737 0.8× 1.1k 1.4× 465 0.8× 211 5.2k
Nicole C. Berchtold United States 27 1.5k 1.2× 1.9k 1.6× 1.4k 1.6× 604 0.8× 571 1.0× 36 5.9k
Greer M. Murphy United States 39 998 0.8× 1.4k 1.2× 709 0.8× 1.1k 1.4× 475 0.8× 90 4.9k
Shlomo Yehuda Israel 36 815 0.7× 1.3k 1.1× 946 1.1× 448 0.6× 323 0.5× 126 4.8k
Sahebarao P. Mahadik United States 39 1.8k 1.5× 828 0.7× 1.9k 2.2× 1.1k 1.4× 722 1.2× 134 5.8k
Christopher D. Breder United States 23 1.6k 1.3× 655 0.6× 1.7k 1.9× 560 0.7× 534 0.9× 37 4.9k
Jonas Hannestad United States 34 875 0.7× 711 0.6× 1.5k 1.7× 933 1.2× 1.1k 1.9× 73 4.9k

Countries citing papers authored by Holger Jahn

Since Specialization
Citations

This map shows the geographic impact of Holger Jahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Jahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Jahn more than expected).

Fields of papers citing papers by Holger Jahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Jahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Jahn. The network helps show where Holger Jahn may publish in the future.

Co-authorship network of co-authors of Holger Jahn

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Jahn. A scholar is included among the top collaborators of Holger Jahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Jahn. Holger Jahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schöttle, Daniel, Klaus Wiedemann, Christoph U. Correll, et al.. (2023). Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly. Schizophrenia Research. 260. 183–190. 1 indexed citations
2.
Shweiki, MHD Rami Al, Petra Steinacker, Patrick Oeckl, et al.. (2019). Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia. Journal of Psychiatric Research. 113. 137–140. 85 indexed citations
3.
Boer, Peter de, Wayne C. Drevets, Hany Rofael, et al.. (2018). A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity. Journal of Psychopharmacology. 32(6). 668–677. 45 indexed citations
4.
Denk, Johannes, Johannes Kornhuber, Jens Wiltfang, et al.. (2018). Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls. PLoS ONE. 13(5). e0197329–e0197329. 69 indexed citations
5.
Barrera-Ocampo, Álvaro, Sönke Arlt, Jakob Matschke, et al.. (2016). Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease. Journal of Neuropathology & Experimental Neurology. 75(9). 903–916. 17 indexed citations
6.
Popp, Julius, Steffen Wolfsgruber, Isabella Heuser, et al.. (2014). Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. Neurobiology of Aging. 36(2). 601–607. 136 indexed citations
7.
Wiedemann, Klaus, Holger Jahn, & James D. Kellner. (2012). Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Experimental and Clinical Endocrinology & Diabetes. 108(1). 5–13. 33 indexed citations
8.
Jahn, Holger, Stefan Wittke, Petra Zürbig, et al.. (2011). Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers. PLoS ONE. 6(10). e26540–e26540. 95 indexed citations
9.
Otte, Christian, Kim Hinkelmann, Steffen Moritz, et al.. (2009). Modulation of the mineralocorticoid receptor as add-on treatment in depression: A randomized, double-blind, placebo-controlled proof-of-concept study. Journal of Psychiatric Research. 44(6). 339–346. 111 indexed citations
10.
Arlt, Sönke, et al.. (2007). The patient with dementia, the caregiver and the doctor: cognition, depression and quality of life from three perspectives. International Journal of Geriatric Psychiatry. 23(6). 604–610. 73 indexed citations
11.
Kiefer, Falk, Holger Jahn, Christian Otte, Helmut Nakovics, & Klaus Wiedemann. (2006). Effects of treatment with acamprosate on β-endorphin plasma concentration in humans with high alcohol preference. Neuroscience Letters. 404(1-2). 103–106. 19 indexed citations
12.
Moritz, Steffen, Beat Meier, Iver Hand, Mildred Schick, & Holger Jahn. (2004). Dimensional structure of the Hamilton Depression Rating Scale in patients with obsessive–compulsive disorder. Psychiatry Research. 125(2). 171–180. 41 indexed citations
13.
Otte, Christian, Holger Jahn, Alexander Yassouridis, et al.. (2003). The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sciences. 73(14). 1835–1845. 43 indexed citations
14.
Raedler, Thomas J., et al.. (2003). Acute effects of megestrol on the hypothalamic?pituitary?adrenal axis. Cancer Chemotherapy and Pharmacology. 52(6). 482–486. 8 indexed citations
15.
Kiefer, Falk, et al.. (2002). Is withdrawal-induced anxiety in alcoholism based on β-endorphin deficiency?. Psychopharmacology. 162(4). 433–437. 42 indexed citations
16.
Kellner, Michael, et al.. (2002). Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy men. Journal of Psychiatric Research. 36(1). 1–6. 20 indexed citations
17.
Otte, Christian, et al.. (2002). Prolactin but not ACTH increases during sodium lactate-induced panic attacks. Psychiatry Research. 109(2). 201–205. 12 indexed citations
18.
Kiefer, Falk, A. Krödel, Holger Jahn, Karsten D. Wolf, & Arnd Barocka. (2000). Harman and norharman plasma levels in weaned alcoholics: correlations with depression and tobacco smoking. Addiction Biology. 5(4). 437–441. 4 indexed citations
19.
Lewczuk, Piotr, Jens Wiltfang, M. Lange, et al.. (1999). Prothrombin Concentration in the Cerebrospinal Fluid Is Not Altered in Alzheimer's Disease. Neurochemical Research. 24(12). 1531–1534. 8 indexed citations
20.
Jahn, Holger. (1984). Cardiocirculatory function in renal disease. KARGER eBooks. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026